BamSEC and AlphaSense Join Forces
Learn More

Galectin Therapeutics Inc.

NASDAQ: GALT    
Share price (12/24/24): $0.84    
Market cap (12/24/24): $52.8 million
Search in Documents
Key Exhibits
External Links

Articles of Incorporation Filter

EX-3
from SC 13D/A 11 pages Galectin Therapeutics, Inc. Amened and Restated Common Stock Purchase Warrant – Class B-3
12/34/56
EX-3.7
from 10-K 4 pages Filed in the Office of Secretary of State State of Nevada Business Number C2038-2001 Filing Number 20232999432 Filed on 3/1/2023 10:00:00 Am Number of Pages 3 Filed in the Office Ofsecretary of Statestate of Nevadabusiness Numberc2038-2001filing Number20232999432filed On3/1/2023 10:00:00 Amnumber of Pages3
12/34/56
EX-3.3
from 8-K 2 pages Certificate of Amendment to Certificate of Designation for Nevada Profit Corporations
12/34/56
EX-3.2
from 8-K 3 pages Certificate of Amendment to Certificate of Designation for Nevada Profit Corporations
12/34/56
EX-3.1
from 8-K 3 pages Certificate of Amendment to Certificate of Designation for Nevada Profit Corporations
12/34/56
EX-3.1
from 8-K 3 pages Certificate of Designation for Nevada Profit Corporations
12/34/56
EX-3.1
from 8-K 13 pages Galectin Therapeutics, Inc. Second Amended and Restated Certificate of Designation of Preferences, Rights and Limitations of Series B-1 Convertible Preferred Stock, Series B-2 Convertible Preferred Stock, and Series B-3 Convertible Preferred Stock Pursuant to Section 78.56 of the Nevada General Corporation Law
12/34/56
EX-3.2
from 10-K 19 pages Amended and Restated Bylaws of Galectin Therapeutics Inc Article 1 Offices Article 2 Stockholders
12/34/56
EX-3.2
from 8-K 3 pages Restated Articles of Incorporation of Galectin Therapeutics Inc
12/34/56
EX-3.1
from 8-K 21 pages Amended and Restated Bylaws of Galectin Therapeutics Inc Article 1 Offices Article 2 Stockholders
12/34/56
EX-3.2
from 10-K 2 pages Articles of Merger of Pro-Pharmaceuticals, Inc. (A Massachusetts Corporation) Into Pro-Pharmaceuticals, Inc
12/34/56
EX-3.1
from 8-K 2 pages Certificate of Change Filed Pursuant to Nrs 78.209 for Nevada Profit Corporations
12/34/56
EX-3.3
from 8-K 2 pages Certificate of Amendment to Articles of Incorporation for Nevada Profit Corporations
12/34/56
EX-3.2
from 8-K 1 page 5. Signature: (Required) /S/ Maureen E. Foley Signature of Officer
12/34/56
EX-3.1
from 8-K 1 page 5. Signature: (Required) /S/ Maureen E. Foley Signature of Officer
12/34/56
EX-3.1
from 8-K 37 pages Pro-Pharmaceuticals, Inc. Amended and Restated Certificate of Designation of Preferences, Rights and Limitations of Series B-1 Convertible Preferred Stock and Series B-2 Convertible Preferred Stock Pursuant to Section 78.56 of the Nevada General Corporation Law
12/34/56
EX-3.1
from 8-K 11 pages Pro-Pharmaceuticals, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series C Super Dividend Convertible Preferred Stock (Variable Cumulative Convertible) Pursuant to Section 78.1955 of the Nevada Revised Statutes
12/34/56
EX-3.1
from 8-K 2 pages Pro-Pharmaceuticals, Inc. Certificate of Amendment No. 2 to Certificate of Designation of Preferences, Rights and Limitations of Series B-1 Convertible Preferred Stock and Series B-2 Convertible Preferred Stock Pursuant to Section 78.1955 of the Nevada General Corporation Law
12/34/56
EX-3.7
from 10-Q 3 pages Pro-Pharmaceuticals, Inc. Certificate of Amendment to Certificate of Designation of Preferences, Rights and Limitations of Series B-1 Convertible Preferred Stock and Series B-2 Convertible Preferred Stock Pursuant to Section 78.1955 of the Nevada General Corporation Law
12/34/56
EX-3.1
from 8-K 1 page Certificate of Amendment to Articles of Incorporation for Nevada Profit Corporations
12/34/56